pills.jpgIPNews® – Prescription giant Merck announced today that it lost its recent patent infringement battle against Canadian competitor Apotex. 

The Canadian company had been accused of illegally selling a copy of Merck’s popular nasal allergy drug Nasonex.  Rather than strictly denying the allegations, Apotex challenged the validity of the Nasonex patent.  To continue reading, click: